Special Issue "Cannabinoids as Medicines"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 November 2018)
The last three decades have seen real advances in the characterization of the body’s endocannabinoid system, with detailed knowledge of cannabinoid receptor subtypes, endocannabinoid metabolic pathways and their cell signaling pathways. In parallel, advocacy, and some sanction, of the use of medicinal marijuana, often based on anecdotal evidence, has become a pertinent topic of societal and scientific debate. At a scientific level, interest has tended to shift away from use of Δ9-tetrahydrocannabinol (THC), due to its psychoactive intoxicant effects, towards alternative plant-derived phytocannabinoids or synthetic cannabinoids and their potential therapeutic applications. Despite some high-profile clinical failures, recent well-controlled clinical trials have begun to advance non-THC cannabinoids towards human therapeutic use. Authors are invited to submit original and review articles of basic science, preclinical and clinical findings contributing to the understanding of the current state of play and future potential for cannabinoids as medicines to be published in this Special Issue of Pharmaceuticals.Prof. Dr. Gary J. Stephens
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cannabinoid therapy